## KMX: CarMax Inc - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($35.97)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. CarMax, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - KMX**
- Source: Morningstar | 20251208T140822 | Neutral | Relevance: 99%
-  The Gross Law Firm has issued a notice to shareholders of CarMax, Inc. (NYSE: KMX) regarding a securities class action lawsuit. The complaint alleges that CarMax issued materially false and misleading statements about its growth prospects during the class period of June 20, 2025, to November 5, 2025. Shareholders who purchased KMX shares during this period are encouraged to contact the firm to potentially be appointed as lead plaintiff, with a deadline of January 2, 2026.

**2. KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: PR Newswire | 20251208T080828 | Neutral | Relevance: 99%
-  The Schall Law Firm is encouraging investors who purchased CarMax, Inc. securities between June 20, 2025, and September 24, 2025, to join a class action lawsuit. The lawsuit alleges that CarMax made false and misleading statements regarding its growth prospects, specifically overstating the reasons for growth in fiscal year 2026. Investors suffered damages when the market learned the truth about the company's performance drivers.

**3. CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX**
- Source: KXAN Austin | 20251208T081745 | Neutral | Relevance: 99%
-  The DJS Law Group has filed a class action lawsuit against CarMax, Inc. (NYSE: KMX) for alleged securities law violations, claiming the company made false and misleading statements regarding its growth prospects between June 20, 2025, and September 24, 2025. Shareholders who purchased KMX shares during this period and suffered losses are encouraged to contact the firm to discuss their rights and potential lead plaintiff appointments. The lawsuit alleges CarMax's growth was driven by customer speculation about tariffs, not sustainable fundamentals.

**4. KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: CBS 42 | 20251208T073813 | Neutral | Relevance: 99%
-  The Schall Law Firm has announced a class action lawsuit against CarMax, Inc. (NYSE: KMX) for alleged securities fraud between June 20, 2025, and September 24, 2025. The lawsuit claims CarMax made misleading statements about its growth prospects, which were reportedly driven by customer speculation about vehicle tariffs rather than sustainable growth. Investors who suffered losses during this period are encouraged to contact the firm to discuss their rights and lead the lawsuit.

**5. KMX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that CarMax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: CBS 42 | 20251207T120816 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against CarMax, Inc. (NYSE:KMX) on behalf of investors who purchased securities between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax made misleading statements regarding its growth prospects, which were reportedly a temporary benefit from tariff speculation rather than sustainable business improvements. Investors who suffered losses have until January 2, 2026, to apply to be lead plaintiff in the case.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $37 | $35 | +6% |
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |
| 2025-11-10 | Morgan Stanley | $35 | $56 | -38% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |
| 2025-11-10 | Morgan Stanley | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 34.1% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.5x). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 1.29 |
| 52W Range | $30.26 - $91.25 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | 13.4 |
| Current P/E | 15.1 |
| YoY Growth | 12.0% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 3.5% to 0.2% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.66x), long-term trend not supportive. MACD histogram positive (0.76), confirming momentum. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.16% (CS: 60) | Neutral |
| RSI_14 | 52.9 | Neutral |
| MACD Histogram | 0.76 | Bullish |
| vs SMA20 | 1.071x | Above |
| vs SMA50 | 0.972x | Below |
| vs SMA200 | 0.659x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.03
- **Stop Loss:** $35.97 (7.8% risk)
- **Target:** $42.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 163
- **Position Value:** $6,361.89
- **Portfolio %:** 6.36%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |
| 2024Q4 | $0.61 | $0.81 | +33.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*